chr2-210675818-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001875.5(CPS1):​c.4252C>T​(p.Pro1418Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00127 in 1,558,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1418L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 0 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: 1.88

Publications

5 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012970537).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000919 (140/152304) while in subpopulation NFE AF = 0.00157 (107/68032). AF 95% confidence interval is 0.00133. There are 0 homozygotes in GnomAd4. There are 63 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.4252C>Tp.Pro1418Ser
missense
Exon 36 of 38NP_001866.2
CPS1
NM_001369256.1
c.4285C>Tp.Pro1429Ser
missense
Exon 37 of 39NP_001356185.1
CPS1
NM_001122633.3
c.4252C>Tp.Pro1418Ser
missense
Exon 37 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.4252C>Tp.Pro1418Ser
missense
Exon 36 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.4270C>Tp.Pro1424Ser
missense
Exon 37 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2899C>Tp.Pro967Ser
missense
Exon 26 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.000920
AC:
140
AN:
152186
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000849
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00157
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000836
AC:
210
AN:
251192
AF XY:
0.000810
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.00189
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00140
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.00131
AC:
1842
AN:
1406192
Hom.:
0
Cov.:
24
AF XY:
0.00126
AC XY:
888
AN XY:
703344
show subpopulations
African (AFR)
AF:
0.0000928
AC:
3
AN:
32326
American (AMR)
AF:
0.000246
AC:
11
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.00178
AC:
46
AN:
25782
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39452
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85170
European-Finnish (FIN)
AF:
0.000712
AC:
38
AN:
53394
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5664
European-Non Finnish (NFE)
AF:
0.00160
AC:
1695
AN:
1061212
Other (OTH)
AF:
0.000820
AC:
48
AN:
58542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
75
150
225
300
375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000919
AC:
140
AN:
152304
Hom.:
0
Cov.:
33
AF XY:
0.000846
AC XY:
63
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41576
American (AMR)
AF:
0.000131
AC:
2
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.000849
AC:
9
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00157
AC:
107
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.000846
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000807
AC:
98
EpiCase
AF:
0.00104
EpiControl
AF:
0.00119

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Congenital hyperammonemia, type I (3)
-
3
-
not provided (3)
-
-
1
CPS1-related disorder (1)
-
1
-
Pulmonary hypertension, neonatal, susceptibility to;C4082171:Congenital hyperammonemia, type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
0.89
L
PhyloP100
1.9
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.39
N
REVEL
Benign
0.28
Sift
Benign
0.37
T
Sift4G
Benign
0.20
T
Polyphen
0.0
B
Vest4
0.068
MVP
0.75
MPC
0.23
ClinPred
0.027
T
GERP RS
6.1
Varity_R
0.24
gMVP
0.68
Mutation Taster
=60/40
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150966847; hg19: chr2-211540542; API